US2003027779A1PendingUtilityA1

Method for inducing DNA synthesis in neurons

Assignee: SPINAL CORD SOCPriority: Dec 17, 1993Filed: Jan 25, 2002Published: Feb 6, 2003
Est. expiryDec 17, 2013(expired)· nominal 20-yr term from priority
C12Y 114/13041C12Y 114/16002C12N 9/0071C07K 14/4738C12N 2710/10322C07K 14/005C12N 15/85C07K 14/48
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method is provided for inducing DNA synthesis in differentiated neurons. According to certain embodiments of the invention, a method for inducing DNA synthesis in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a differentiated neuron, and transfecting a differentiated neuron with the vector. According to certain embodiments of the invention, a method for integrating DNA encoding a desired protein in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a neuron, obtaining DNA encoding a desired protein, and cotransfecting a differentiated neuron with the vector and the DNA encoding the desired protein such that the DNA encoding the desired protein is integrated in the differentiated neuron and the desired protein is produced.

Claims

exact text as granted — not AI-modified
20 . (Twice Amended) A method for inducing nucleic acid synthesis in a differentiated neuron in vivo comprising: 
 obtaining at least one vector comprising nucleic acid encoding a desired protein and an E2F regulator or an E1A regulator, or both an E2F regulator and an E1A regulator;    wherein the vector is injected into or near the peripheral nervous system and is not injected into the brain or the central nervous system of an animal.    
     
     
         22 . (Once Amended) A method as in  claim 20 , wherein the vector(s) are associated with immunoliposomes.  
     
     
         23 . (Once Amended) A method as in  claim 20  wherein the vector(s) comprise pRcCMV.  
     
     
         24 . (Once Amended) A method as in  claim 23 , wherein the vector(s) comprise the E2F regulator.  
     
     
         25 . (Once Amended) A method as in  claim 23 , wherein the vector(s) the E2F1 regulator.  
     
     
         26 . (Once Amended) A method as in  claim 23 , wherein the vector(s) comprise the E1A regulator.  
     
     
         27 . (Twice Amended) A method for integrating DNA encoding a desired protein in a differentiated neuron in vivo comprising: 
 obtaining a vector comprising nucleic acid encoding an E2F regulator, an E1A regulator, or both an E2F regulator and an E1A regulator, wherein the vector can be used to express the DNA encoding a desired protein in a neuron;    obtaining DNA encoding a desired protein; and    cotransfecting a differentiated neuron with the vector and the DNA encoding the desired protein such that the DNA encoding the desired protein is integrated in the differentiated neuron and the desired protein is produced;    wherein the vector is injected into or near the peripheral nervous system and is not injected into the brain or the central nervous system of an animal.    
     
     
         37 . A vector comprising nucleic acid encoding at least one regulator selected from the group consisting of E2F and E1A.  
     
     
         38 . The vector of  claim 37  comprising at least one expression control sequence.  
     
     
         39 . The vector of  claim 38  wherein the expression control sequence is chosen from the group consisting of promoters and enhancers.  
     
     
         40 . A vector comprising nucleic acid encoding at least one regulator selected from the group consisting of E2F, E2F1, E2F2, E2F3, and E1A.  
     
     
         41 . The vector of  claim 40  comprising pRcCMV.  
     
     
         42 . The vector of  claim 40  wherein one of the desired proteins is L-DOPA.  
     
     
         43 . The vector of  claim 40  wherein one of the desired proteins is tyrosine hydroxylase.  
     
     
         44 . The vector of  claim 40  wherein one of the desired proteins is a neurotrophic factor.  
     
     
         45 . The vector of  claim 40  wherein the vector comprises a DNA sequence for a marker protein.  
     
     
         46 . The vector of  claim 45  wherein the marker protein is a fluorescent protein.  
     
     
         47 . The vector of  claim 45  wherein the marker protein is an enzyme.  
     
     
         48 . The vector of  claim 47  wherein the enzyme is β-galactosidase.  
     
     
         49 . The vector of  claim 40  comprising DNA encoding for nerve growth factor (NGF).  
     
     
         50 . An improved method of inducing neurons to express DNA encoding a desired protein of the type wherein the DNA encoding the desired protein is introduced into the neuron, the improvement comprising: 
 cotransfecting the DNA encoding the desired protein with nucleic acids encoding at least one of the members of the group consisting of E2F and E1A.    
     
     
         51 . The method of  claim 50  wherein the E2F is chosen from the group consisting of E2F1, E2F2, and E2F3.  
     
     
         52 . An improved vector for inducing a differentiated cell to express DNA encoding a desired protein of the type wherein the vector is introduced into the differentiated cell, the improvement in the vector comprising: 
 nucleic acids encoding at least one of the members of the group consisting of E2F and E1A.    
     
     
         53 . The method of  claim 50  wherein the E2F is chosen from the group consisting of E2F1, E2F2, and E2F3.  
     
     
         54 . An improved method of inducing neurons to express DNA encoding a desired protein of the type wherein the DNA encoding the desired protein is introduced into the neuron, the improvement comprising: 
 introducing DNA encoding the desired protein in combination with factors that bind to Rb.    
     
     
         55 . The method of  claim 54  wherein the factor that binds to Rb is an antibody.  
     
     
         56 . The method of  claim 54  wherein the factor that binds to Rb is E2F.

Join the waitlist — get patent alerts

Track US2003027779A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.